Profile
| Metric | Value |
|---|---|
| Full Name | Veeva Systems Inc. |
| Ticker | NYSE: VEEV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Health Information Services |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | veeva.com |
| Employees | 7,291 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $219.49 | |
| Price, 1D Change | -1.68% | |
| Market Cap | $36B | |
| - | ||
| PE Ratio | 42.65 | |
| Beta | 0.61 | |
| Revenue | $3B | |
| Revenue, 1Y Change | +16.20% | |
| EPS | $4.32 | |
| EPS, 1Y Change | +34.41% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $4.32 | |
| EPS Estimate | $7.93 | |
| EPS Est. Change | +83.55% | |
| Revenue | $2.75B | |
| Revenue Estimate | $3.17B | |
| Revenue Est. Change | +15.42% | |
| Current Price | $219.49 | |
| Price Target | - | $320.00 |
| Price Tgt. Change | - | +45.79% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.76 | $3.22 | -32.45% | |
| $6.45 | $4.32 | -33.02% | |
| $7.93 | N/A | +83.55% | |
| $8.58 | N/A | +98.46% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.35B | $2.36B | +0.40% | |
| $2.72B | $2.75B | +0.82% | |
| $3.17B | N/A | +15.42% | |
| $3.55B | N/A | +29.42% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +4.23% | |
| Price, 3Y | +36.01% | |
| Market Cap, 1Y | +5.54% | |
| Market Cap, 3Y | +43.60% | |
| Revenue, 1Y | +16.20% | |
| Revenue, 3Y | +48.40% | |
| EPS, 1Y | +34.41% | |
| EPS, 3Y | +64.10% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $219.49 | |
| SMA 200 | $263.59 | |
| SMA 200 vs Price | +20.09% | |
| SMA 50 | $256.11 | |
| SMA 50 vs Price | +16.68% | |
| Beta | 0.61 | |
| ATR | $5.51 | |
| 14-Day RSI | 28.04 | |
| 10-Day Volatility | 15.61% | |
| 1-Year Volatility | 34.67% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.75B | |
| EPS | $4.32 | |
| Gross Profit | $2.05B | |
| Gross Margin | 74.53% | |
| Operating Profit | $691.44M | |
| Operating Margin | 25.17% | |
| Net Income | $714.14M | |
| Net Margin | 26.00% | |
| EBITDA | $730.82M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.01 | |
| Current Ratio | 4.51 | |
| Quick Ratio | 4.51 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 16.51 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 42.65 | |
| PS Ratio | 11.71 | |
| PB Ratio | 5.12 | |
| EV/EBITDA | 31.36 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $5.83B | |
| Cash & Equivalents | $5.15B | |
| Total Assets | $7.34B | |
| Current Assets | $6.31B | |
| Total Liabilities | $1.51B | |
| Current Liabilities | $1.40B | |
| Total Debt | $75.78M | |
| Short Term Debt | $9.97M | |
| Accounts Payable | $30.45M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $2.06B | |
| Operating Expenses | $1.36B | |
| Cost Of Goods Sold | $699.64M | |
| SG&A | $662.47M | |
| D&A | $39.38M | |
| Interest Expense | $0.00 | |
| Income Tax | $205.24M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.09B | |
| CFI | -$700.14M | |
| CFF | $26.12M | |
| Capex | $20.52M | |
| Free Cash Flow | $1.09B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Keybanc | → | |
| Wells Fargo | → | |
| Citigroup | → | |
| UBS | → | |
| Needham | → | |
| Canaccord Genuity | → | |
| Barclays | → | |
| Baird | → | |
| BTIG | → | |
| BMO Capital |
Analyst sentiment
Institutional ownership
Screeners with VEEV
Data Sources & References
- VEEV Official Website www.veeva.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1393052/000139305225000078/0001393052-25-000078-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1393052/000139305225000022/0001393052-25-000022-index.htm
- VEEV Profile on Yahoo Finance finance.yahoo.com/quote/VEEV
- VEEV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/veev
FAQ
What is the ticker symbol for Veeva Systems Inc.?
The ticker symbol for Veeva Systems Inc. is NYSE:VEEV
Does Veeva Systems Inc. pay dividends?
No, Veeva Systems Inc. does not pay dividends
What sector is Veeva Systems Inc. in?
Veeva Systems Inc. is in the Healthcare sector
What industry is Veeva Systems Inc. in?
Veeva Systems Inc. is in the Health Information Services industry
What country is Veeva Systems Inc. based in?
Veeva Systems Inc. is headquartered in United States
When did Veeva Systems Inc. go public?
Veeva Systems Inc. initial public offering (IPO) was on October 16, 2013
Is Veeva Systems Inc. in the S&P 500?
No, Veeva Systems Inc. is not included in the S&P 500 index
Is Veeva Systems Inc. in the NASDAQ 100?
No, Veeva Systems Inc. is not included in the NASDAQ 100 index
Is Veeva Systems Inc. in the Dow Jones?
No, Veeva Systems Inc. is not included in the Dow Jones index
When was Veeva Systems Inc. last earnings report?
Veeva Systems Inc.'s most recent earnings report was on November 20, 2025
When does Veeva Systems Inc. report earnings?
The next expected earnings date for Veeva Systems Inc. is March 4, 2026